North America to Dominate Drug Discovery Informatics Market until 2025
Growing geriatric population
suffering from various diseases is expected to drive the growth of global drug
discovery informatics market
According to
TechSci Research report, “Global Drug
Discovery Informatics Market By Component (Software v/s Service), By
Function (Sequencing and Target Data Analysis, Docking, Molecular Modelling,
Library & Database Preparation, Clinical Trial Data Management, Others), By
Mode (In-house Informatics v/s Outsourced), By Application (Drug Discovery v/s
Drug Development), By End User (Pharmaceutical Companies, Biotechnology
Companies, Contract Research Organization (CROs), Others), By Region, Forecast
& Opportunities, 2025”, the global drug discovery
informatics market is expected to grow at a formidable rate during the forecast
period on account of the growing prevalence of infectious, chronic and rare
diseases. Additionally, the sudden outbreak and spread of pandemic COVID-19,
which has adversely impacted the world with no available treatment or medicine
available, is expected to positively influence the market growth through 2025.
Furthermore, improving healthcare IT infrastructure is further expected to spur
the market growth during the forecast period. Besides, use of advanced
technologies such as machine learning, bioinformatics, AI, blockchain, among
others in drug discovery is further expected to create lucrative opportunities
for the market growth until 2025. Moreover, increasing R&D activities for
novel molecule discovery is expected to propel the market growth over the next
few years. However, high cost of use and deployment of informatics software might
hamper the market growth during the forecast period. Also, the dearth of
skilled professionals might further impede the market growth.
Browse XX
market data Tables and XX Figures spread through XX
Pages and an in-depth TOC on " Global Drug Discovery Informatics Market"
https://www.techsciresearch.com/report/drug-discovery-informatics-market/4957.html
The global
drug discovery Informatics market is segmented based on component, function,
mode, application, end user, company and region. Based on Based on function,
the market can be fragmented into sequencing and target data analysis, docking,
molecular modelling, library & database preparation, clinical trial data
management and others. Among these, the sequencing and target analysis segment
is expected to dominate the market. This can be ascribed to the increased
application for sequencing analysis for the new drug entities and ease of
handling of information from different sources. Based on mode, the market can
be bifurcated into in-house informatics and outsourced. Here, the outsourced
segment is expected to hold a significant market share owing to the associated
benefits such as access to advanced & innovative technologies, increased
production, shorter timelines, reduced risks, focus on core competencies, among
others. Based on end user, the market can be fragmented into pharmaceutical
companies, biotechnology companies, contract research organization (CROs) and
others. Among these, the pharmaceutical companies are projected to hold the
largest market share on account of the widespread use of informatics software
for research and development of drugs.
Jubilant
Life Sciences Limited, IBM Corporation, Clarivate Analytics, Eurofins
Scientific, Thermo Fisher Scientific, Accenture PLC, PerkinElmer Inc,
Schrödinger, Inc., Certara L.P., Evotec AG and others are some of the leading
players operating in global drug discovery informatics market. The companies operating
in the market are using organic strategies such as product launches, mergers
and collaborations to boost their share.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4957
Customers can
also request for 10% free customization on this report.
“North America is expected to dominate
the drug discovery informatics market during the forecast period, owing to the
prevalence of various chronic diseases such as diabetes, cancer, CVD, among
others in the region. Furthermore, presence of major market players in the
region along with well-established CROs is expected to fuel the market growth
through 2025. Additionally, increasing investments by major biopharmaceutical
and biotechnology companies coupled with new product launches is expected to
create lucrative opportunities for the market growth during the forecast
period.” said Mr. Karan Chechi, Research Director with TechSci Research, a
research based global management consulting firm.
“Global Drug Discovery Informatics Market By
Component (Software v/s Service), By Function (Sequencing and Target Data
Analysis, Docking, Molecular Modelling, Library & Database Preparation,
Clinical Trial Data Management, Others), By Mode (In-house Informatics v/s
Outsourced), By Application (Drug Discovery v/s Drug Development), By End User
(Pharmaceutical Companies, Biotechnology Companies, Contract Research
Organization (CROs), Others), By Region, Forecast & Opportunities, 2025”, has evaluated the future growth potential of global drug
discovery informatics market and provides statistics & information on
market size, structure and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges and opportunities in global drug
discovery informatics market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]